Compare HAL & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HAL | IQV |
|---|---|---|
| Founded | 1919 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Oilfield Services/Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9B | 28.6B |
| IPO Year | 2006 | 2013 |
| Metric | HAL | IQV |
|---|---|---|
| Price | $38.78 | $181.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 16 |
| Target Price | $38.61 | ★ $227.13 |
| AVG Volume (30 Days) | ★ 9.3M | 1.7M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.63% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | 0.55 | ★ 1.61 |
| Revenue | ★ $17,973,000,000.00 | $9,739,000,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | $4.19 | $5.89 |
| P/E Ratio | ★ $71.56 | $112.06 |
| Revenue Growth | 22.47 | ★ 41.60 |
| 52 Week Low | $19.53 | $151.58 |
| 52 Week High | $43.59 | $247.05 |
| Indicator | HAL | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 40.99 | 62.40 |
| Support Level | $38.83 | $176.99 |
| Resistance Level | $43.03 | $191.78 |
| Average True Range (ATR) | 1.17 | 6.77 |
| MACD | -0.44 | 0.94 |
| Stochastic Oscillator | 7.55 | 91.37 |
Halliburton is North America's largest oilfield-services company as measured by market share. Despite industry fragmentation, it holds a leading position in the hydraulic fracturing and completions market, which makes up nearly half of its revenue. It also holds strong positions in other service offerings like drilling and completions fluids, which leverages its expertise in material science, as well as the directional drilling market. While we consider SLB the global leader in reservoir evaluation, we think Halliburton leads in any activity from the reservoir to the wellbore. Halliburton's innovations have helped multiple producers lower their development costs per barrel of oil equivalent, with techniques that have been honed over a century of operations.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.